-
2
-
-
0025120749
-
The ETS-domain: A new DNA binding motif that recognizes a purine-rich core DNA sequence
-
(1990)
Genes Dev
, vol.4
, pp. 1451
-
-
Karim, F.D.1
Urness, L.D.2
Thummel, C.S.3
Klemsz, M.J.4
McKercher, S.R.5
Celada, A.6
Van Beveren, C.7
Maki, R.A.8
Gunther, C.V.9
Nye, J.A.10
-
4
-
-
0242549003
-
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
-
(1996)
EMBO J
, vol.15
, pp. 5647
-
-
McKercher, S.R.1
Torbett, B.E.2
Anderson, K.L.3
Henkel, G.W.4
Vestal, D.J.5
Baribault, H.6
Klemsz, M.7
Feeney, A.J.8
Wu, G.E.9
Paige, C.J.10
-
9
-
-
0033587755
-
Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 8705
-
-
Zhang, P.1
Behre, G.2
Pan, J.3
Iwama, A.4
Wara-Aswapati, N.5
Radomska, H.S.6
Auron, P.E.7
Tenen, D.G.8
Sun, Z.9
-
11
-
-
0029978734
-
Spi-1/PU.1 transgenic mice develop multistep erythroleukemias
-
(1996)
Mol. Cell. Biol.
, vol.16
, pp. 2453
-
-
Moreau-Gachelin, F.1
Wendling, F.2
Molina, T.3
Denis, N.4
Titeux, M.5
Grimber, G.6
Briand, P.7
Vainchenker, W.8
Tavitan, A.9
-
13
-
-
0028810739
-
Lymphoid- and myeloid-specific activity of the PU.1 promoter is determined by the combinatorial action of octamer and ets transcription factors
-
(1995)
Oncogene
, vol.11
, pp. 1095
-
-
Kistler, B.1
Pfisterer, P.2
Wirth, T.3
-
14
-
-
0028826488
-
PU.1 (Spi-1) autoregulates its expression in myeloid cells
-
(1995)
Oncogene
, vol.11
, pp. 1549
-
-
Chen, H.M.1
Ray-Gallet, D.2
Zhang, P.3
Hetherington, C.J.4
Gonzalez, D.A.5
Zhang, D.E.6
Moreau-Gachelin, F.7
Tenen, D.G.8
-
18
-
-
0032030770
-
Histone acetylation and transcriptional regulatory mechanisms
-
(1998)
Genes Dev
, vol.12
, pp. 599
-
-
Struhl, K.1
-
19
-
-
0034654011
-
Acetylation: A regulatory modification to rival phosphorylation?
-
(2000)
EMBO J
, vol.19
, pp. 1176
-
-
Kouzarides, T.1
-
25
-
-
0034671618
-
Activation of MHC class I, II and CD40 gene expression by histone deacetylase inhibitors
-
(2000)
J. Immunol.
, vol.165
, pp. 7017
-
-
Magner, W.J.1
Kazim, A.L.2
Stewart, C.3
Romano, M.A.4
Catalano, G.5
Grande, C.6
Keiser, N.7
Santaniello, F.8
Tomasi, T.B.9
-
27
-
-
0032879920
-
Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in adult myeloid leukemias: A new approach to anti-leukemia therapy
-
(1999)
Leukemia
, vol.13
, pp. 1316
-
-
Kosugi, H.1
Towatari, M.2
Hatano, S.3
Kitamura, K.4
Kiyoi, H.5
Kinoshita, T.6
Tanimoto, M.7
Murate, T.8
Kawashima, K.9
Saito, H.10
-
30
-
-
0033520944
-
Histone deacetylase inhibitor selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and anti-proliferative effects
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 34940
-
-
Sambucetti, L.C.1
Fischer, D.D.2
Zabludoff, S.3
Kwon, P.O.4
Chamberlin, H.5
Trogani, N.6
Xu, H.7
Cohen, D.8
-
36
-
-
0033214311
-
PU.1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation
-
(1999)
Blood
, vol.94
, pp. 2310
-
-
Anderson, K.L.1
Smith, K.A.2
Perkin, H.3
Hermanson, G.4
Anderson, C.G.5
Jolly, D.J.6
Maki, R.A.7
Torbett, B.E.8
-
43
-
-
0035221154
-
Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event
-
(2001)
Nat. Immunol.
, vol.2
, pp. 51
-
-
Weinman, A.S.1
Mitchell, D.M.2
Sanjabi, S.3
Bradley, M.N.4
Hoffmann, A.5
Liou, H.C.6
Smale, S.T.7
|